Amazon-Berkshire-JPMorgan Health Venture Takes Aim At Middlemen
(Bloomberg) -- The health venture established by Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. will take aim at intermediaries in the health-care system as a part of a broad effort to reduce wasteful spending, the venture's newly named chief executive officer said.
The still-unnamed business will initially seek to develop ways to improve care for the more than 1 million individuals who get health insurance from the three firms. Over time, the venture will make those innovations available freely to other companies, meaning that if it's successful, its effects could be felt more broadly among the more than 150 million people in the U.S. who get their health insurance through work.
“My job for them is to figure out ways that we're going to drive better outcomes, better satisfaction with care and better cost efficiency with new models that can be incubated for all,” Atul Gawande, the Harvard surgeon and journalist who was named last week to run the initiative, said Saturday at an Aspen Institute event.
Gawande, 52, starts July 9 at the Boston-based business, which is independent of the three firms that established it and not intended to generate profits. The companies have collectively said little about what the venture will do since announcing it in January, prompting broad speculation about its plans for upending health care.
Gawande said the venture will seek to target three kinds of waste in the health-care system: administrative costs, high prices, and improper health-care usage. He didn't say which intermediaries the venture might target, or what its plans are.
Attacking Costs
“One source of waste is our very high administrative costs,” he said during a conversation with journalist Judy Woodruff at the Spotlight Health event. “There are a lot of middlemen in the system, and there have to be solutions that simplify that, take some of the middlemen out of the system.”
When the venture was announced, investors sent shares of health insurers, pharmacy-benefits managers and distributors lower, worried that the initiative would pressure their profits. Gawande's remarks at the event are the most detailed to date about his plans and may confirm some of those concerns.
The biggest U.S. pharmacy-benefits managers are CVS Health Corp., Express Scripts Holding Co. and UnitedHealth Group Inc.'s OptumRx unit. UnitedHealth is the biggest U.S. health insurer, and other large carriers include Cigna Corp., Aetna Inc. and Anthem Inc.
The health industry has been reconfiguring itself, too. CVS late last year announced a deal to acquire Aetna, and Cigna in March agreed to buy Express Scripts.
Gawande also said the venture has a long time horizon, echoing past remarks from Berkshire CEO Warren Buffett and JPMorgan CEO Jamie Dimon. He raised questions about the future role of employers in the U.S. health-care system, as workers increasingly move between jobs or work in many smaller roles that don't provide insurance in the gig economy.
“Tying how you get your health to your place of employment is going to become less and less tenable as fewer and fewer people are getting coverage through their employment,” he said. Gawande supports government-guaranteed health insurance for all.
“Even though I'm going to work for a bunch of employers, employer-based care is broken,” Gawande said.
To contact the reporter on this story: Zachary Tracer in New York at ztracer1@bloomberg.net
To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Kevin Miller, Bernard Kohn
©2018 Bloomberg L.P.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.